134 related articles for article (PubMed ID: 12968150)
1. An ethical dilemma.
Rose H
Nature; 2003 Sep; 425(6954):123-4. PubMed ID: 12968150
[No Abstract] [Full Text] [Related]
2. Canadian lab loses Amgen backing.
Knight J
Nature; 2002 May; 417(6884):4. PubMed ID: 11986629
[No Abstract] [Full Text] [Related]
3. The ethics of research using biobanks: reason to question the importance attributed to informed consent.
Hoeyer K; Olofsson BO; Mjörndal T; Lynöe N
Arch Intern Med; 2005 Jan; 165(1):97-100. PubMed ID: 15642883
[TBL] [Abstract][Full Text] [Related]
4. Governing population genomics: law, bioethics, and biopolitics in three case studies.
Winickoff DE
Jurimetrics; 2003; 43(2):187-228. PubMed ID: 15156881
[TBL] [Abstract][Full Text] [Related]
5. Biotechnology for consumer use: Voluntary, non-medical, DNA identity banks as commodity products.
Scheinman A
Am J Pharmacogenomics; 2004; 4(2):69-72. PubMed ID: 15059029
[TBL] [Abstract][Full Text] [Related]
6. Beyond release: the equitable use of genomic information.
Sulston J
Lancet; 2003 Aug; 362(9381):400-2. PubMed ID: 12907016
[No Abstract] [Full Text] [Related]
7. Cementing links between industry and the university.
Jennings R
Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
[No Abstract] [Full Text] [Related]
8. Technology managers do their bit for world health.
Stevens AJ
Nature; 2005 Jun; 435(7042):561. PubMed ID: 15931194
[No Abstract] [Full Text] [Related]
9. Navigating an ethical patchwork--human gene banks.
Maschke KJ
Nat Biotechnol; 2005 May; 23(5):539-45. PubMed ID: 15877066
[No Abstract] [Full Text] [Related]
10. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
11. Ethical, legal, and social issues in genetic testing for complex genetic diseases.
Andrews L; Zuiker ES
Valparaiso Univ Law Rev; 2003; 37(3):793-829. PubMed ID: 15378818
[No Abstract] [Full Text] [Related]
12. The complexities of ethical evaluation of genomics research.
Hoedemaekers R; Gordijn B; Hekster Y; van Agt F
HEC Forum; 2006 Mar; 18(1):18-36. PubMed ID: 17076127
[No Abstract] [Full Text] [Related]
13. Sale of the century: Iceland has come to grief over the human genome. Do we have to?
New Sci; 2000 Feb; 165(2226):3. PubMed ID: 11885623
[No Abstract] [Full Text] [Related]
14. The SNP consortium: summary of a private consortium effort to develop an applied map of the human genome.
Holden AL
Biotechniques; 2002 Jun; Suppl():22-4, 26. PubMed ID: 12083393
[No Abstract] [Full Text] [Related]
15. Blurred vision.
Smaglik P
Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
[No Abstract] [Full Text] [Related]
16. From genetic privacy to open consent.
Lunshof JE; Chadwick R; Vorhaus DB; Church GM
Nat Rev Genet; 2008 May; 9(5):406-11. PubMed ID: 18379574
[TBL] [Abstract][Full Text] [Related]
17. Clear vision for a structure-seeking business.
Harris T
Nat Biotechnol; 2000 Oct; 18(10):1017. PubMed ID: 11016992
[No Abstract] [Full Text] [Related]
18. Upending the zeitgeist.
Nature; 2006 Jun; 441(7093):572-3. PubMed ID: 16738631
[No Abstract] [Full Text] [Related]
19. Ethics of population genomics research.
Gulcher JR; Stefansson K
Nature; 1999 Jul; 400(6742):307-8. PubMed ID: 10432103
[No Abstract] [Full Text] [Related]
20. Boston: a magnetic hub.
Smaglik P
Nature; 2002 May; 417(6886):4-5. PubMed ID: 12015552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
